Below is a video of Dr. Christina Sanchez, a molecular biologist at Compultense University in Madrid, Spain, clearly explaining how THC (the main psychoactive constitute of the cannabis plant) completely kills cancer cells.
Cannabinoids refer to any group of related compounds that include cannabinol and the active constituents of cannabis. They activate cannabinoid receptors in the body. The body itself produces compounds called endocannabinoids and they play a role in many processes within the body that help to create a healthy environment. I think it’s also important to note that cannabis has been shown to treat cancer without any psychoactive effects.
Cannabinoids have been proven to reduce cancer cells as they have a great impact on the rebuilding of the immune system. Although not every strain of cannabis has the same effect, more and more patients are seeing success in cancer reduction in a short period of time by using cannabis. Contrary to popular belief, smoking cannabis does not assist a great deal in treating disease within the body as therapeutic levels cannot be reached through smoking. Creating oil from the plant or eating the plant is the best way to go about getting the necessary ingredients, the cannabinoids.
The world has come a long way with regards to accepting this plant as a medicine rather than a harmful substance. It’s a plant that could benefit the planet in more ways than one. Cannabis is not something offered in the same regard as chemotherapy, but more people are becoming aware if it, which is why it’s so important to continue to spread information like this. Nobody can really deny the tremendous healing power of this plant.
At 10 months of age, Kalel Santiago of Puerto Rico was diagnosed with a rare form of cancer called neuroblastoma. He endured chemotherapy, radiation treatments, and surgery for two years—and survived. Then he was diagnosed with something permanent: severe autism that disabled him from speaking.
“While he was in the hospital, we noticed he didn’t speak at all and had some behavior that wasn’t right, like hand flapping, and walking on his toes,” his father Abiel Gomez Santiago told Yahoo News. “But we waited until he was 3 and cancer-free to look at his behavior.”
According to Yahoo, “He and his wife Gladys — also parents to two older boys, now 18 and 20 — did a cram course in educating themselves on autism. They tried various schools and therapies and eventually found impressive success with a unique surf-therapy school near their home.”
Eventually, the Santiago family stumbled upon a treatment of real potency and potential: CBD oil.
Through a fundraising program, they were able to receive a tiny bottle of the oil. Kalel was given oral doses twice a day.
Within just two days, he was finally able to speak. “He surprised us in school by saying the vowels, A-E-I-O-U. It was the first time ever,” Abiel said. “You can’t imagine the emotion we had, hearing Kalel’s voice for the first time. It was amazing. The teacher recorded him and sent it to my wife and me and we said well, the only different thing we have been doing is using the CBD.”
Soon after, he began using consonants, too, speaking like his parents never thought possible. “He said, ‘amo mi mama,’ ‘I love my mom,’” Abiel says. “I don’t know how to thank [the CBD oil makers].”
Kalel’s story is yet another piece of evidence piling onto the mountain of support for cannabis oil and full marijuana legalization. Please share this with as many people as possible.
Originally published September 28, 2018 at http://yourhealthdoc.com/autistic-boy-gains-ability-to-speak-after-just-2-days-of-cannabis-oil-treatment-3/?fbclid=IwAR2GwbvayI5NzVBMgdjmfVCJvFAzGCbOn6bAt-5g9POSSKJ4LvYTYLRryrA
A group including 12 former heads of state has called for drugs to be legalized worldwide, as the war on drugs has ‘failed’, a report published today said.
The report ‘Regulation: The Responsible Control of Drugs’ by the Global Commission on Drug Policy found that arresting drug dealers has had little effect.
Instead, governments should introduce regulated markets for drugs – and turn away from global policies which require prohibition and punishment. Should weed be legalised worldwide?
‘The international drug control system is clearly failing,’ said Helen Clark, a former prime minister of New Zealand.
‘The health … of nations is not advanced by the current approach to drug control.’
‘Current drug policies are reducing neither the demand nor the supply of illegal drugs, quite the contrary, while the increasing power of organized crime is a sad reality,’ writes Ruth Driefuss, the former president of Switzerland and chair of the commission.
By taking control of illegal drug markets, the report argues governments can weaken the powerful criminal gangs that have grown despite decades of efforts to stamp them out. Cesar Gaviria, former president of Colombia Source: Bloomberg Mexico’s President-elect Andres Manuel Lopez Obrador
The commission chose to launch its report in Mexico, whose criminal gangs are top suppliers of heroin, methamphetamine, cocaine and marijuana to the United States and where gang-related violence has driven murders to a record high.
‘Mexico is the most important country in the fight against drugs,’ said former Colombian president Cesar Gaviria.
Mexico’s recent history exemplifies the report’s claim that evidence shows arresting drug traffickers has little impact on drug supply and may increase violence. Should drugs be legalised? Yes No Yes, but only soft drugs like weed
Just over 10 years ago, Mexico intensified its battle with drug gangs by sending out the military to battle traffickers.
While dozens of kingpins have been captured or killed, the number of gangs operating in Mexico has multiplied as new criminal leaders step into the breach and battle over turf.
The commission recommends governments open participatory processes to shape reforms toward regulation.
Incoming Mexican President-elect Andres Manuel Lopez Obrador has already started to hold town-hall reviews on violence and discuss potential ‘amnesty’ for non-violent drug traffickers and farmers. Members of his team have said Mexico will evaluate creating legal markets for marijuana as well as opium.
The report calls for a renegotiation of the international treaties that created a ‘repressive’ strategy where drug users and low-level dealers face stiff prison sentences, but it cautions nations are far from a global consensus yet.
Originally published by: Rob Waugh Monday 24 Sep 2018 8:39 am at https://metro.co.uk/2018/09/24/former-world-leaders-call-for-worldwide-legalisation-as-war-on-drugs-has-failed-7973392/
Dr. Lee Cowden says most people don’t die from cancer; they die from the side effects of treatment. While the “war against cancer” is moving toward more personalized and so-called “precision medicine” treatments, the old standby model of “cut, poison and burn,” via surgery, chemotherapy and radiation, is still widely used and regarded as the standard of care for many cancer cases.
One of the major problems with chemotherapy is its indiscriminate toxicity, which poisons your body systemically in an attempt to knock out cancer cells. There have long been signs that this model has fatal flaws and may cause more harm than good. In the case of the breast cancer chemotherapy drug Tamoxifen, for instance, patients must trade one risk for another, as while it may reduce breast cancer, it more than doubles women’s risk of uterine cancer.1
Serious, sometimes-fatal side effects (or more aptly, simply effects) of chemotherapy are common, as are serious unforeseen effects that may make your cancer prognosis worse instead of better.
Writing in the journal Science Translational Medicine, researchers from the Albert Einstein College of Medicine revealed that giving chemotherapy prior to surgery for breast cancer may promote disease metastasis, or the growth and spread of cancer to other areas of the body.2 This, in turn, greatly increases a woman’s risk of dying from the disease.
Chemotherapy May Make Breast Cancer More Aggressive and Likely to Spread
Preoperative chemotherapy, known as neoadjuvant chemotherapy, is often offered to women because it may help shrink tumors, which increases the likelihood that women will receive lumpectomy surgery instead of a full mastectomy. After performing tests on mice and human tissue, however, the researchers found that doing so may increase the likelihood of metastasis by increasing what are known as “tumor microenvironments of metastasis.” As Stat News explained:3
“Called ‘tumor microenvironments of metastasis,’ these on-ramps are sites on blood vessels that special immune cells flock to. If the immune cells hook up with a tumor cell, they usher it into a blood vessel like a Lyft picking up a passenger. Since blood vessels are the highways to distant organs, the result is metastasis, or the spread of cancer to far-flung sites.”
When mice with breast cancer or given human breast tumors were given the chemotherapy, it altered the tumor microenvironment in ways that made them more conducive to cancer spread, including, Stat reported:4
Increasing the number of immune cells that transport cancer cells into blood vessels
Making blood vessels more permeable to cancer cells
Making tumor cells more mobile
In mice, chemotherapy treatment doubled the number of cancer cells in the bloodstream and lungs compared to mice that did not receive the treatment. Further, in 20 human patients who received common chemotherapy drugs, the tumor microenvironments also became more favorable to cancer spread. As The Telegraph noted:
“It is thought the toxic medication switches on a repair mechanism in the body which ultimately allows tumors to grow back stronger. It also increases the number of ‘doorways’ on blood vessels which allow cancer to spread throughout the body.”5
Further, researchers wrote in a 2012 Journal of Clinical Oncology editorial, “Unfortunately, neoadjuvant chemotherapy does not seem to improve overall survival, as demonstrated in the National Surgical Adjuvant Breast and Bowel Project (NSABP) B18 trial, among others.”6 This means women may be trading a potential increased risk of cancer metastasis for a treatment that doesn’t even improve their chances of survival.
It’s Been Known for Years That Chemotherapy Can Trigger Tumor Growth
While the news that chemotherapy may encourage cancer spread may sound surprising, it’s not a new discovery. In 2012, researchers found chemotherapy for prostate cancer caused DNA damage in healthy cells and caused them to secrete more of a protein called WNT16B, which boosts tumor growth and may encourage cancer cells to develop resistance to treatment.
“WNT16B, when secreted, would interact with nearby tumor cells and cause them to grow, invade and, importantly, resist subsequent therapy,” study co-author Dr. Peter Nelson, of the Fred Hutchinson Cancer Research Center, told AFP News.7
In the journal Nature Medicine, the researchers further noted, “The expression of WNT16B in the prostate tumor microenvironment attenuated the effects of cytotoxic chemotherapy in vivo, promoting tumor cell survival and disease progression”8 and “ … [D]amage responses in benign cells … may directly contribute to enhanced tumor growth kinetics.”9
While research continues to reveal that chemotherapy’s effects are wide-reaching and devastating to healthy cells, it’s also been shown — at least as far back as 2004 — that “chemotherapy only makes a minor contribution to cancer survival.”10 A Clinical Oncology study found that in terms of five-year survival rates in adult cancer cases, chemotherapy has an average five-year survival success rate of just 2.3 percent in Australia and 2.1 percent in the U.S.11
Separate research revealed that out of nearly 2,000 patients receiving chemotherapy, 161 deaths occurred within 30 days of the treatment. Nearly 8 percent of them were classified as related to the chemotherapy (and another nearly 16 percent were unclassified due to insufficient information).12
Further, as mentioned, chemotherapy can increase the risk of subsequent cancer, such as therapy-related acute myeloid leukemia (tAML), “a rare but highly fatal complication of cytotoxic chemotherapy.” Researchers noted that tAML cases occur nearly five times more often in adults treated with chemotherapy than they do in the general population.13
Conventional Oncologists Aren’t Likely to Explain the Many Options for Treatment
Upon receiving a cancer diagnosis, many people assume their only options for treatment are chemotherapy, surgery or radiation. Only you and your health care team can make the decision on how to best pursue treatment, but you should know that conventional providers are unlikely to think outside the box.
Oncology is the only specialty in medicine that is allowed and even encouraged to sell drugs at massive profits — typically in excess of 50 percent — and cancer drugs are, as a general category, the most expensive medications in all of medicine to begin with. Oncologists actually get a commission for the chemotherapy drugs they sell, and with that type of incentive, it’s nearly impossible to imagine them actively seeking other alternatives.
Oncologists are further constrained by the “standard of care” prescribed by oncology medical boards and the drug industry. If they go against the established standard of care, they’re susceptible to having their license reprimanded or even taken away. As a result, patients are typically forced to go it alone if they don’t want to go the conventional route, which is unfortunate because there are many promising alternative treatments.
Understanding Your Options for Cancer Treatment
A comprehensive natural cancer-fighting approach would be to make your body as healthy as possible, using detoxification, strategies to boost your immune function, dietary changes and other targeted therapies depending on your needs. For instance, Annie Brandt — a 16-year cancer survivor and author of “The Healing Platform: Build Your Own Cure!” — states products that are helpful against metastatic cancer cells include:
The point is that there are many anti-cancer strategies overlooked by conventional medicine. Many of them even work in addition to conventional treatment. For instance, vitamin C in combination with nutritional ketosis and fasting prior to administering chemotherapy radically improve the effectiveness of chemotherapy.
Oncologists in Turkey, who aren’t under the same U.S. restrictions, are also using a stacked ketogenic treatment protocol that is showing shocking remissions in many stage 4 cancer patients. The treatment protocol at ChemoThermia Oncology Center in Turkey includes:
At the center, all oncology patients are put on a ketogenic diet, which creates metabolic stress on the cancer cells. Then, prior to administering the chemo, the patient will do a 14-hour fast, which further increases the metabolic stress on the cancer cells.
The patients will typically have a blood glucose level around 80 milligrams per deciliter (mg/dL) at this point. They then apply glycolysis inhibitors to inhibit the glycolysis pathway in the cancer cells, which creates a terrific amount of metabolic stress, as the cancer cells are already starved of glucose.
Insulin is then applied to lower the blood glucose levels to around 50 or 60 mg/dL, to cause mild hypoglycemia. At that point, chemotherapy is applied, often at a far lower dose than would otherwise be used, thereby lowering the risk of side effects.
In the days following chemotherapy, hyperthermia and hyperbaric oxygen therapy are applied, plus a daily infusion of glycolysis inhibitor therapies with high-dose vitamin C (50 grams) and dimethyl sulfoxide (DMSO). A sampling of other targeted therapies covered in Brandt’s book are below.
Poly-MVA, a colloidal mineral complex that crosses the blood-brain barrier and helps renourish your body and brain at the cellular level. It also helps replace nutrients lost during chemotherapeutic and radiological treatments.
AvéULTRA (Metatrol), a fermented wheat germ product.
Selenium, vitamin D and iodine, as most cancer patients are low in these three nutrients. Since I do regular sauna therapy, I take 200 micrograms of SelenoExcell each day. (You tend to excrete selenium when sweating.) Selenium increases glutathione, an important metabolic antioxidant necessary for detoxification. It also catalyzes the conversion of thyroid hormone T4 to T3, so it can be beneficial if you have thyroid problems.
Modified citrus pectin (MCP) has been shown to reverse cancer and stop metastatic cancer. Brandt recommends the brand ecoNugenics, as this is the one that has been scientifically studied and verified to work.
Colloidal silver is a nontoxic, broad-spectrum antimicrobial therapy with no known toxicity and no known mechanism for acquired resistance.
Salicinium, a plant-based extract that inhibits production of nagalase — an enzyme produced by cancer cells — while simultaneously stimulating innate immune cells.
So as mentioned, there are many promising avenues to target cancer. Even if you’re working with a conventional oncologist, the ChemoThermia Oncology Center has published protocols your oncologist could make use of, regardless of where you live. If your oncologist isn’t willing to integrate these alternative strategies into your care regimen, you may want to consider finding a new doctor.
Originally published by: By Dr. Mercola at https://articles.mercola.com/sites/articles/archive/2017/07/25/chemotherapy-spreading-cancer.aspx?utm_source=facebook.com&utm_medium=referral&utm_content=facebookmercola_ranart&utm_campaign=20181007_chemotherapy-spreading-cancer&fbclid=IwAR1_QSRot3NmbJ0SmGLkFzRYTrksEv-XZwqi_Pt-LT2pZy1i239kHXTZqHg
Yolanda Ng was on the cusp of a full time job as a pediatric nephrologist at Providence Sacred Heart Children’s Hospital in Spokane, Washington, in the summer of 2014. She was going through the motions of onboarding at the hospital—filling out paperwork and finalizing her new position. Then she took a drug test, and it came back positive for cannabis use.
A few months prior, Ng had started to take a few drops from a cannabis-infused tincture that her friend recommended to help with menstrual cramps for a few days every month when she had her period. She tells me that it was such a small amount that she’d had no concerns about giving the requisite urine sample. Weed was already decriminalized in Washington at the time, and Ng says she had never used cannabis at work or before seeing patients.
But when the positive result came back, her supervisor said it was protocol to report her to the state’s physician health program, an organization tasked with protecting the public from unsafe medical practice. What followed was a costly and messy process of legal proceedings, suspended licenses, mandatory rehab, and regulatory middlemen—a process that pushed Ng to decide to leave the field altogether.
Now Ng’s story is another cautionary tale, adding to a growing number from medical professionals facing repercussions for using medical and recreational cannabis in the 23 states where it has been decriminalized. As the country continues to push for legalization, the lack of clarity and regulation within the medical establishment is leaving physicians in the crosshairs with little guidance and often fewer rights than other working citizens.
“The law doesn’t provide paths forward for [physicians like Ng],” says Nicole Li, an attorney who represents Ng and several other physicians who have faced similar issues as a result of both authorized medical and adult cannabis use. “Resolving the situation is going to require a political solution prompted by political pressure.”
Cases like Ng’s have cropped up across the country. There’s the neurosurgery resident in California who said she smoked weed on her days off. Or one of Li’s current clients in Washington who was only reported and tested when a patient complained about him after he refused to prescribe unnecessary opioids. Physician Paul Bregman in Colorado lost his medical license after he used marijuana as a treatment for bipolar disorder.
There are no specific laws that govern what a physician can and cannot do when it comes to cannabis. It’s widely accepted that a doctor cannot legally practice if his or her work is compromised by any drug—be it opioids, alcohol, or weed. But marijuana poses a specific challenge since the substance can stay in your system, and show up on drug tests, for up to a month after use. There is no way to distinguish between someone who smoked a joint in the morning before work and one who did so three weeks ago on a weekend.
Sometimes the rules around whether or not a doctor can use cannabis depends on the workplace, not the state. Micah Matthews, deputy executive and legislative director for the Washington Medical Commission, the state licensing agency, says that hospitals or clinics that accept federal dollars often have to comply with federal, not state, regulations. And under the US law, marijuana is still a Schedule I—i.e., illegal—drug.
“An employer may not have a problem with recreational use,” he says, “but if they accept federal money, as all hospitals tend to do, that creates some requirements for continued funding should cannabis use be discovered.”
The grey area, however, is not just about what is permitted. It’s also about who determines what happens to physicians who are found using cannabis. This task often falls to physician health programs, semi-voluntary organizations that are meant to direct physicians to rehab or report dangerous behavior. State licensing boards, like the one in Washington, often defer to these organizations to evaluate the physicians and recommend a course of action.
Physician health programs are controversial in the medical community, and have been criticized for forcing doctors into unnecessary treatment. There’s also the chance that these programs have a financial interest in sending physicians to costly treatment centers. “They’re pursuing our clients when there are dangerous doctors out there,” Li says, referring to physicians who put their patients’ safety at risk.
When psychiatrist Michael Alpert in Cambridge, Massachusetts, created a Change.org petition to protect doctors who use marijuana safely, the petition was directed at the Federation of State Physician Health Programs, which oversees the state programs. (Full disclosure: I know Alpert socially).
When I reached out to Chris Bundy, the director of Washington’s physician health program, he told me that his organization tries to address and rehabilitate doctors so that they don’t have their licenses revoked. He also emphasizes that the organization believes that regular cannabis use (which he defined as at least weekly) leads to cognitive impairment, and shouldn’t be used by doctors, especially since it is federally illegal.
“How would we know or define safe limits for physicians?” he says. “The danger is the assumption that most people have that getting drunk or high on Sunday won’t impact practice performance on Monday.”
There is a dearth of research on the long-term use of cannabis, and we still don’t know if using the drug has permanent impact on cognitive functioning in adults. But Bundy says the program would never make a decision about referral for evaluation, treatment or monitoring based only on the frequency of cannabis use. Instead, he says it has to be evaluated in the context of the other clinical information available. (Bundy didn’t comment on any specific cases.)
Doctors have spoken out against the state programs and their treatment of doctors in the past, saying the programs are not looking out for physicians like Ng. “Mandating people go for evaluations at physician health programs solely on the basis of a marijuana test is ridiculous,” says J. Wesley Boyd, a physician and associate professor of psychiatry at Harvard Medical School. “The fact that the state board of medicine in Washington state went along with that is appalling.”
In Ng’s case, the physician health program she was referred to conducted an interview, determined they couldn’t make a conclusion, and referred her to Hazelden Betty Ford Foundation Center, an addiction program, for a $5000, three-day evaluation. And while the psychologist and psychiatrist determined she wasn’t at risk, Ng tells me that one of the program’s counselors decided she had “severe substance abuse” and that her marijuana use had permanently impacted her brain.
They then recommended that she enter a three-month inpatient rehabilitation program at the same center, which would have required her to pay $50,000. When she didn’t comply, she was reported to the Washington Medical Quality Assurance Commission. “There were some people who legitimately needed to be there,” she says. “I don’t understand why I qualified.”
The misunderstanding and lack of research around cannabis use can have severe repercussions on a physician’s career, not to mention their well-being. Li says that none of the clients she’s currently representing had been reported for threatening a patient’s safety. But even then, some of their names appeared in local media, stating that they were reported for using illegal drugs.
“Physicians call me from across the country—they don’t know what kind of lawyer they need. There’s shame and stigma around it,” Li says. “The amount of suicide talk is alarming.”
Meanwhile, Ng, now living in California, says she wants to leave her past, and the stress of her three-year ordeal, behind. After hearing the requirements for probation—working every day, and remaining 100 miles away from the original hospital—she hung up her white coat entirely and is now working as an interior designer.
Originally published at: https://tonic.vice.com/en_us/article/vbknb4/doctors-using-legal-weed-suspended
A double-blind placebo-controlled study with 24 patients suffering from Tourette syndrome was conducted at the Medical School of Hannover, Germany. The 6-week trial confirmed results of two earlier short-term studies by Dr. Kirsten Mueller-Vahl and colleagues that THC is effective in the reduction of tics.
The Tourette syndrome is a complex neurological-psychiatric disorder characterized by motor tics (sudden spasms especially in the face, the neck and the shoulders) and one or more vocal tics. In many cases, it is associated with behavioural problems or psychopathologies (autoaggression, disturbed attention, etc.). Presently, neuroleptics are the most effective drugs. However, neuroleptics are not effective in all patients and in many cases, are not well tolerated.
Patients were treated over a period of 6 weeks. The dosage was titrated to the target dosage of 10 mg THC. Starting at 2.5 mg/day, the dose was increased by increments of 2.5 mg/day every 4 days. Tic severity was rated using several established scales.
Seven patients dropped out of the study or had to be excluded, but only one due to side effects. Application of THC resulted in a significant improvement of tic severity. No serious adverse effects occurred. Authors concluded that the “results provide more evidence that THC is effective and safe in the treatment of tics.”
HM. Delta-9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial. J Clin Psychiatry 2003;64(4):459-465)
Originally published May 2003 at: http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=146&fbclid=IwAR1uE-15QDzTcbn_QKrkTlSOv_SfsN3VJ5Tf_9Sjqr8r2TMWdDl0kbH24U0#1
Analysis from New Frontier Data, a firm that focuses on the marijuana industry, also found that the federal government would create at least $131.8 billion in federal tax revenue over the next eight years if cannabis were legalized in all 50 states.
With federal legalization, there would be 782,000 jobs created immediately, and the firm forecasts that the number would increase to 1.1 million by 2025, including growers and retailers.
In 2015, a year after Colorado legalized recreational cannabis sales, the legal marijuana industry created 18,000 full-time jobs and $2.4 billion in economic growth in the state, according to the Marijuana Policy Group. New Frontier suggested this trend could be sustainable on a national level.
“If cannabis businesses were legalized tomorrow and taxed as normal businesses with a standard 35 percent tax rate, cannabis businesses would infuse the U.S. economy with an additional $12.6 billion this year,” New Frontier CEO Giadha Aguirre De Carcer told the Washington Post.
The economic growth would be pushed by increased demand on various industries, according to the Marijuana Policy Group. Farmers need warehouse space, and they purchase specialized equipment like lighting and irrigation for marijuana growth. Retailers rely on contractors and book-keeping services to run businesses. In states like Washington and Colorado, legal recreational marijuana has also led to a boost in some tourism sectors.
California became the eighth state to sell legal recreational marijuana on January 1, and 29 states now allow medical marijuana. Federal legalization, while popular across nearly every demographic group in the U.S., is facing renewed challenges from U.S. Attorney General Jeff Sessions, whose strong opposition to statewide marijuana laws has slowed the bipartisan push. Sessions last week rescinded an Obama-era rule that told federal prosecutors to leave marijuana alone in states that legalized it, leaving open questions about the future of the burgeoning industry.
Originally published by: SUMMER MEZA ON 1/11/18 AT 6:29 PM
Western medicine has some good points, and is great in an emergency, but it’s high time people realized that today’s mainstream medicine (western medicine or allopathy), with its focus on drugs, drugs, radiation, drugs, surgery, drugs and more drugs, is at its foundation a money spinning Rockefeller creation.
People these days look at you like a weirdo if you talk about the healing properties of plants or any other holistic practices. Much like anything else, politics and money have been used to warp people’s minds and encourage them to embrace what is bad for them.
It all began with John D. Rockefeller (1839 – 1937) who was an oil magnate, a robber baron, America’s first billionaire, and a natural-born monopolist.
By the turn on the 20th century, he controlled 90% of all oil refineries in the U.S. through his oil company, Standard Oil, which was later on broken up to become Chevron, Exxon, Mobil etc.
World Affairs reports: At the same time, around 1900, scientists discovered “petrochemicals” and the ability to create all kinds of chemicals from oil. For example, the first plastic — called Bakelite — was made from oil in 1907. Scientists were discovering various vitamins and guessed that many pharmaceutical drugs could be made from oil.
This was a wonderful opportunity for Rockefeller who saw the ability to monopolize the oil, chemical and the medical industries at the same time!
The best thing about petrochemicals was that everything could be patented and sold for high profits.
But there was one problem with Rockefeller’s plan for the medical industry: natural/herbal medicines were very popular in America at that time. Almost half the doctors and medical colleges in the U.S. were practicing holistic medicine, using knowledge from Europe and Native Americans.
Rockefeller, the monopolist, had to figure out a way to get rid of his biggest competition. So he used the classic strategy of “problem-reaction-solution.” That is, create a problem and scare people, and then offer a (pre-planned) solution. (Similar to terrorism scare, followed by the “Patriot Act”).
He went to his buddy Andrew Carnegie – another plutocrat who made his money from monopolizing the steel industry – who devised a scheme. From the prestigious Carnegie Foundation, they sent a man named Abraham Flexner to travel around the country and report on the status of medical colleges and hospitals around the country.
This led to the Flexner Report, which gave birth to the modern medicine as we know it.
Needless to say, the report talked about the need for revamping and centralizing our medical institutions. Based on this report, more than half of all medical colleges were soon closed.
Homeopathy and natural medicines were mocked and demonized; and doctors were even jailed.
To help with the transition and change the minds of other doctors and scientists, Rockefeller gave more than $100 million to colleges, hospitals and founded a philanthropic front group called “General Education Board” (GEB). This is the classic carrot and stick approach.
In a very short time, medical colleges were all streamlined and homogenized. All the students were learning the same thing, and medicine was all about using patented drugs.
Scientists received huge grants to study how plants cured diseases, but their goal was to first identify which chemicals in the plant were effective, and then recreate a similar chemical – but not identical – in the lab that could be patented.
A pill for an ill became the mantra for modern medicine.
And you thought Koch brothers were evil?
So, now we are, 100 years later, churning out doctors who know nothing about the benefits of nutrition or herbs or any holistic practices. We have an entire society that is enslaved to corporations for its well-being.
America spends 15% of its GDP on healthcare, which should be really called “sick care.” It is focused not on cure, but only on symptoms, thus creating repeat customers. There is no cure for cancer, diabetes, autism, asthma, or even flu.
Why would there be real cures? This is a system founded by oligarchs and plutocrats, not by doctors.
As for cancer, oh yeah, the American Cancer Society was founded by none other than Rockefeller in 1913.
Originally published at: http://ehealthmagz.com/2018/08/17/how-rockefeller-founded-big-pharma-and-waged-war-on-natural-cures/
The contemporary version of argument can be traced to a 2012 Duke University study, which found that persistent, heavy marijuana use through adolescence and young adulthood was associated with declines in IQ.
Other researchers have since criticized that study’s methods. A follow-up study in the same journal found that the original research failed to account for a number of confounding factors that could also affect cognitive development, such as cigarette and alcohol use, mental illness and socioeconomic status.
Two new reports this month tackle the relationship between marijuana use and intelligence from two very different angles: One examines the life trajectories of 2,235 British teenagers between ages 8 and 16, and the other looks at the differences between American identicaltwin pairs in which one twin uses marijuana and the other does not.
Despite vastly different methods, the studies reach the same conclusion: They found no evidence that adolescent marijuana use leads to a decline in intelligence.
I wrote about the study of British teenagers before, when it was still a working paper. It has been peer-reviewed and accepted for publication, and its findings still stand: After adjusting for a range of confounding factors, such as maternal health, mental health and other substance use, the researchers found that “cannabis use by the age of 15 did not predict either lower teenage IQ scores or poorer educational performance. These findings therefore suggest that cannabis use at the modest levels used by this sample of teenagers is not by itself causally related to cognitive impairment.”
They did find, though, a distinct relationship between cigaretteuse and poor educational performance, which is in line with what other research has found. The researchers did not find a robust link between cigarette use and IQ.
The authors of this study stress that their results don’t necessarily invalidate the findings of the 2012 Duke University paper. That paper focused on persistent heavy use over a long period of time, while this study looked only at low to moderate levels of adolescent use. “While persistent cannabis dependence may be linked to declining IQ across a person’s lifetime,” the authors write, “teenage cannabis use alone does not appear to predict worse IQ outcomes in adolescents.”
But the researchers in the study of American twins tackle the Duke University findings head-on. Examining the life trajectories of twin pairs in which one uses marijuana while the other doesn’t, they found that those who used marijuana didn’t experience consistently greater cognitive deficits than the others.
Identicaltwin comparisons are a powerful tool for this kind of analysis, because their genetic makeup is nearly identical and their early home environment is consistent. This automatically controls for a lot of the confounding factors that can make sussing out causality difficult.
The twin data “fails to support the implication by Meier et. al. [the authors of the Duke study] that marijuana exposure in adolescence causes neurocognitive decline,” the study concludes. The numbers suggest, on the contrary, that “children who are predisposed to intellectual stagnation in middle school are on a trajectory for future marijuana use.” In other words, rather than marijuana making kids less intelligent, it may be that kids who are not as smart or who perform poorly in school are more inclined to try marijuana at some point in their lives.
Also, if marijuana use were responsible for cognitive decline, you might expect to find that the more marijuana a person smokes, the less intelligent they become. But this paper found that heavier marijuana use was not associated with greater decreases in IQ.
Originally published by: Christopher Ingraham on January 18, 2016 at: https://www.washingtonpost.com/news/wonk/wp/2016/01/18/scientists-have-found-that-smoking-weed-does-not-make-you-stupid-after-all/
